A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE)
- PMID: 8803889
- DOI: 10.1177/096120339600500305
A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE)
Abstract
The aim of the present investigation was to assess and compare health status instruments in SLE. One hundred and twenty-five patients completed five health status instruments: the Health Assessment Questionnaire (HAQ), Functional Ability Index, the Fatigue Severity Scale (FSS), the Disability Days Measure (DDM), the Centre for Epidemiological Studies-Depression Scale (CES-D), and the Medical Outcomes Study (MOS) Short Form Health Survey during their Clinic visit. Disease activity was measured using the SLE Disease Activity Index (SLEDAI). All instruments described a spectrum of quality of life outcomes in these patients. An inter-instrument correlation analysis revealed that components of the MOS correlated significantly with each of the other instruments used. There was no correlation between any of the instruments used and the SLEDAI. We conclude that health status assessment as measured by the MOS short form is a valid independent outcome measure in patients with SLE.
Similar articles
-
Quality-of-life measurements versus disease activity in systemic lupus erythematosus.Curr Rheumatol Rep. 2010 Aug;12(4):250-8. doi: 10.1007/s11926-010-0114-1. Curr Rheumatol Rep. 2010. PMID: 20586000 Review.
-
Fatigue in lupus is not correlated with disease activity.J Rheumatol. 1998 May;25(5):892-5. J Rheumatol. 1998. PMID: 9598886
-
Lack of correlation among the 3 outcomes describing SLE: disease activity, damage and quality of life.Clin Exp Rheumatol. 1996 May-Jun;14(3):305-8. Clin Exp Rheumatol. 1996. PMID: 8809446
-
The minimally important difference for patient reported outcomes in systemic lupus erythematosus including the HAQ-DI, pain, fatigue, and SF-36.J Rheumatol. 2009 Oct;36(10):2231-7. doi: 10.3899/jrheum.090193. Epub 2009 Sep 1. J Rheumatol. 2009. PMID: 19723907
-
Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-85-95. Epub 2014 Oct 30. Clin Exp Rheumatol. 2014. PMID: 25365095 Review.
Cited by
-
Health-related quality of life assessed by LupusQoL questionnaire and SF-36 in Turkish patients with systemic lupus erythematosus.Clin Rheumatol. 2016 Mar;35(3):617-22. doi: 10.1007/s10067-015-2930-1. Epub 2015 Apr 7. Clin Rheumatol. 2016. PMID: 25846834
-
Quality-of-life measurements versus disease activity in systemic lupus erythematosus.Curr Rheumatol Rep. 2010 Aug;12(4):250-8. doi: 10.1007/s11926-010-0114-1. Curr Rheumatol Rep. 2010. PMID: 20586000 Review.
-
Causal cascade of direct and indirect effects of anifrolumab on patient-reported outcomes: structural equation modelling of two Phase 3 trials.Rheumatology (Oxford). 2022 Nov 28;61(12):4731-4740. doi: 10.1093/rheumatology/keac138. Rheumatology (Oxford). 2022. PMID: 35274691 Free PMC article. Clinical Trial.
-
Endogenous type-I interferon activity is not associated with depression or fatigue in systemic lupus erythematosus.J Neuroimmunol. 2010 Jun;223(1-2):13-9. doi: 10.1016/j.jneuroim.2010.03.018. Epub 2010 Apr 22. J Neuroimmunol. 2010. PMID: 20416954 Free PMC article.
-
BMI, disease activity, and health-related quality-of-life in systemic lupus erythematosus.Clin Rheumatol. 2010 Dec;29(12):1413-7. doi: 10.1007/s10067-010-1477-4. Epub 2010 May 2. Clin Rheumatol. 2010. PMID: 20437067
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical